Heart Transplant Rejection
📧 Sign up to get email alerts when something new happens for Heart Transplant Rejection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-03Clinical Trial Results: Precision Guided Tacrolimus Dosing in Pediatric Heart Transplant [NA]
Clinical trial results for precision-guided tacrolimus dosing in pediatric heart transplant recipients have been completed with results post…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Surveillance HeartCare® Outcomes Registry
An ongoing observational registry (HeartCare Outcomes Registry by CareDx) evaluating heart transplant rejection outcomes; the study is activ…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A National Swedish Study Evaluating Dd-cfDNA for as a Diagnostic Biomarker for Rejection Surveillence in Heart Transplantation
Karolinska Institutet is conducting a national Swedish study to evaluate donor-derived cell-free DNA as a diagnostic biomarker for rejection…
-
FDA approval · 2026-03-18FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for mycophenolate mofetil from Aurobindo Pharma Limited under an ANDA.
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Trifecta-Heart cfDNA-MMDx Study
The Trifecta-Heart cfDNA-MMDx Study led by the University of Alberta is currently recruiting participants to evaluate donor-derived cell-fre…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: TTV Viral Load in Heart Transplant Recipients
A completed clinical trial evaluated Torque Teno Virus viral load in heart transplant recipients. The study explored potential associations …
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: A Comparative Effectiveness Study in Heart Transplant Patients of Rejection Surveillance With Cell-free DNA Versus Endomyocardial Biopsy [NA]
This clinical trial compares cell-free DNA rejection surveillance with endomyocardial biopsy in heart transplant patients and is currently a…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Mobile Video Directly Observed Therapy (DOT) for Immunosuppression Medication Adherence in Adolescent Heart Transplant Recipients [NA]
This clinical trial is evaluating a mobile video directly observed therapy to improve adherence to immunosuppressive medications in adolesce…
-
FDA approval · 2026-02-23FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Amneal Pharmaceuticals NY LLC)
The FDA approved Amneal Pharmaceuticals NY LLC's supplemental application for Mycophenolate mofetil (generic) under the ANDA, approving chan…
-
FDA approval · 2026-01-21FDA Approved: CYCLOSPORINE — Original Application (Upsher-Smith Laboratories, LLC)
FDA approved Upsher-Smith's original ANDA for generic cyclosporine.
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: IMR-Heart Trasplant Study
Clinical trial is currently recruiting for IMR-Heart to evaluate its use in heart transplant rejection and related microvascular issues.
-
FDA approval · 2025-10-17FDA Approved: TACROLIMUS — Supplemental Application (NORTHSTAR RX LLC)
The FDA approved a supplemental application for tacrolimus (generic) submitted by NORTHSTAR RX LLC.
-
CLINICAL_TRIALS trial_result · 2025-10-08Clinical Trial Update: Phase II Study Evaluating the Efficacy of Tacrolimus Extended Release Tablets to Twice Daily Tacrolimus Dosing Regimen [Phase 2]
Phase II study evaluating whether tacrolimus extended-release tablets are as effective as standard twice-daily tacrolimus dosing in heart tr…
-
FDA approval · 2025-09-26FDA Approved: TACROLIMUS — Supplemental Application (Biocon Pharma Inc.)
FDA approved Biocon Pharma Inc.'s supplemental application for tacrolimus, updating labeling to support its use in preventing organ transpla…
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: Valganciclovir vs. Letermovir for CMV Prophylaxis in Heart Transplant [Phase 2, Phase 3]
A Phase 2/3 clinical trial compares valganciclovir with letermovir for CMV prophylaxis in heart transplant recipients and is currently recru…
-
FDA approval · 2025-06-27FDA Approved: MYHIBBIN — Supplemental Application (Azurity Pharmaceuticals, Inc.)
FDA approved a supplemental application for MYHIBBIN (mycophenolate mofetil) submitted by Azurity Pharmaceuticals, Inc. The supplement perta…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Prospera Test Evaluation in Cardiac Transplant (ProTECT)
The document provides a status update on the Prospera test evaluation in heart transplant rejection (ProTECT), indicating the trial is curre…
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: HEARTBiT: Multi-Marker Blood Test for Acute Cardiac Transplant Rejection
This clinical trial update describes the HEARTBiT multi-marker blood test for detecting acute cardiac transplant rejection, with the study c…
-
CLINICAL_TRIALS research · 2025-02-17Clinical Trial Update: Allograft Dysfunction in Heart Transplant [Phase 4]
Phase 4 clinical trial update on allograft dysfunction in heart transplant recipients; the study is currently recruiting.
-
FDA approval · 2025-02-12FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Strides Pharma Science Limited)
The FDA approved a supplemental application for mycophenolate mofetil from Strides Pharma Science Limited.
-
FDA approval · 2025-02-12FDA Approved: TACROLIMUS — Original Application (Nexus Pharmaceuticals, LLC)
Generic tacrolimus from Nexus Pharmaceuticals has been approved through an original ANDA for use in preventing organ transplant rejection.
-
CLINICAL_TRIALS research · 2025-01-14Clinical Trial Update: CARdiac Imaging and BIomarkers in the Diagnosis of Antibody Mediated Rejection in Heart Transplantation
This clinical trial aims to evaluate cardiac imaging and biomarkers for diagnosing antibody-mediated rejection in heart transplant recipient…
-
CLINICAL_TRIALS research · 2025-01-07Clinical Trial Update: Precision Guided Tacrolimus Dosing in Pediatric Heart Transplant [NA]
A pediatric heart transplant trial is testing precision-guided tacrolimus dosing and is currently not recruiting.
-
FDA approval · 2024-11-07FDA Approved: MYCOPHENOLATE MOFETIL — Original Application (Wuxi Fortune Pharmaceutical Co.,Ltd.)
The FDA approved the original application for a generic mycophenolate mofetil formulation from Wuxi Fortune Pharmaceutical Co., Ltd.
-
FDA approval · 2024-10-22FDA Approved: MYCOPHENOLATE MOFETIL — Original Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' original application for a generic mycophenolate mofetil product.